BioVie Inc (BIVI)

[someconcerns]

New stock offering after 1 for 125 reverse split:

This is a firm commitment public offering of shares of Class A common stock (“common stock”) of BioVie Inc. Prior to this offering, there has been a limited public market for our common stock on the OTCQB Marketplace under the ticker BIVI. We are selling up to shares of common stock. There are no selling shareholders in this offering.



On June 26, 2019, the last reported sale price for our common stock as reported on the OTCQB Marketplace was $11.88 per share, after giving effect to our planned 1:125 reverse stock split. The final public offering price will be determined through negotiation between us and the lead underwriters in the offering and the recent market price used throughout this prospectus may not be indicative of the final offering price. We have applied to list our common stock on The NASDAQ Capital Market under the symbol “BIVI,” which listing is a condition to this offering. No assurance can be given that our application will be approved. This offering will only occur if NASDAQ approves the listing of our common stock on NASDAQ. If NASDAQ does not approve the listing of our common stock, we will not proceed with this offering.